Daiichi Sankyo Nordics ApS
CVR 39371049 · Private limited company (ApS) · Active · Low risk
Daiichi Sankyo Nordics ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 40.3m and a net result of DKK 17.3m. CEO: Christophe Tiberghien.
Bankruptcy risk for Daiichi Sankyo Nordics ApS
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39371049
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Amagerfælledvej 106, 2.
2300 København S - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 100k
- Employees
- 2 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 12.9% |
| Current ratio | 114% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 5 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 48 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Gross profit | DKK 83.6m | DKK 69.5m | DKK 57.4m |
| Net profit | DKK 17.3m | DKK 9.0m | DKK 8.4m |
| Equity | DKK 40.3m | DKK 23.1m | DKK 14.1m |
| Total assets | DKK 313.2m | DKK 261.5m | DKK 181.3m |
| Cash | DKK 98.5m | DKK 28.4m | – |
| Short-term debt | DKK 272.9m | DKK 238.4m | – |
| Tax owed | DKK 3.5m | DKK 3.3m | – |
| Avg. employees | 41 | 38 | – |
Latest annual report: Reporting class C, medium-size enterprise · auditor's statement: Independent Auditor’s Report · KPMG.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 197 | Late | |
| 1 Apr 2024 – 31 Mar 2025 | 186 | Late | |
| 1 Apr 2023 – 31 Mar 2024 | 199 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 185 | Late | |
| 1 Apr 2021 – 31 Mar 2022 | 183 | ||
| 1 Apr 2020 – 31 Mar 2021 | 168 | ||
| 1 Apr 2019 – 31 Mar 2020 | 175 | ||
| 28 Feb 2018 – 31 Mar 2019 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christophe Tiberghien | Current | |
| CEO | Nicola Torosantucci | ||
| CEO | Åke Magnus Gisel | ||
| Board | Karin Margaretha Heisterberg | Current | |
| Board | Jacob Wessel-Tolvig | Current | |
| Board | Christophe Tiberghien | Current | |
| Board | Stefan Gerd Koch | ||
| Board | Patrik Josef Mag. Grandits | ||
| Board | Stefan Gerd Koch | ||
| Board | Tim Ellmers | ||
| Board | Nicola Torosantucci | ||
| Board | Åke Magnus Gisel | ||
| Owner (100%) | Daiichi Sankyo Oncology Europe GmbH | Current | |
| Auditor | KPMG P/S | Current | |
| Founder | Ulrik Fleischer-Michaelsen | Current |
Address history (2 moves)
| Amagerfælledvej 106, 2., 2300 København S | |
| Amagerfælledvej 106, 2., 2300 København S | |
| c/o Copenhagen Bio Science Park, Ole Maaløes Vej 3, 2200 København N |
Former names
| Daiichi Sankyo Nordics ApS | – now |
| Daiichi Sankyo Oncology Nordics ApS | – |
Employees per year
Other companies at the same address
- 0xTHREE ApS Bankrupt
- Appstract Consulting ApS Bankrupt
- Bancore A/S Bankrupt
- European Institute of Innovation, Entrepreneurship, and Technology ApS Bankrupt
- JBRD Komplementar ApS Bankrupt
- PENTAMARK GROUP IVS Bankrupt
- Paytech Invest A/S Bankrupt
- Selskabet af 13.10.2015 ApS Bankrupt
- Talentiir ApS Bankrupt
- ALLERGYCERTIFIED ApS Active
- Acentio A/S Active
- Alcora ApS Active
- Ardoq Denmark ApS Active
- Checkin ApS Active
- Cliio ApS Active
- Crypta ApS Opløst
- DIAKRIT DANMARK ApS Active
- Elaway ApS Active
- EyeReply ApS Active
- FISCHER & KERRN A/S Active
- Feedr ApS Active
- Get Lit Denmark ApS Active
- Get Lit Holding ApS Active
- HverdagsAI ApS Active
- Joulia ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Daiichi Sankyo Nordics ApS
Has Daiichi Sankyo Nordics ApS gone bankrupt?
No, Daiichi Sankyo Nordics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Daiichi Sankyo Nordics ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Daiichi Sankyo Nordics ApS?
Christophe Tiberghien is the CEO of Daiichi Sankyo Nordics ApS.
Who is the auditor of Daiichi Sankyo Nordics ApS?
Daiichi Sankyo Nordics ApS most recently used KPMG P/S.
When was Daiichi Sankyo Nordics ApS founded?
Daiichi Sankyo Nordics ApS was founded on 28 February 2018.
What is the equity of Daiichi Sankyo Nordics ApS?
Equity was DKK 40.3m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.